Cargando…
Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma
Cisplatin (CDDP) is one of the front-line chemotherapeutic drugs used in the treatment of esophageal squamous cell carcinoma (ESCC). Occurrence of resistance to CDDP has become one of the main challenges in cancer therapy. In this study, the gene expression profile of CDDP-resistant ESCC cells was i...
Autores principales: | Chan, Dessy, Zhou, Yuanyuan, Chui, Chung Hin, Lam, Kim Hung, Law, Simon, Chan, Albert Sun-chi, Li, Xingshu, Lam, Alfred King-yin, Tang, Johnny Cheuk On |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210716/ https://www.ncbi.nlm.nih.gov/pubmed/30241323 http://dx.doi.org/10.3390/cells7100143 |
Ejemplares similares
-
Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells
por: Zhou, Yuanyuan, et al.
Publicado: (2019) -
Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE(2)
por: Pun, Ivan Ho Yuen, et al.
Publicado: (2017) -
The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican
por: Zhou, Yuanyuan, et al.
Publicado: (2022) -
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma
por: Chung, Po Yee, et al.
Publicado: (2018) -
MicroRNA‐338‐5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id‐1
por: Han, Liang, et al.
Publicado: (2019)